Condition
Sports Drug Abuse
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Unknown2
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04965961Not ApplicableUnknownPrimary
The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females
NCT04402658Not ApplicableWithdrawnPrimary
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
NCT03028532Phase 1CompletedPrimary
Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting
NCT03276910Phase 1UnknownPrimary
Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents
Showing all 4 trials